Therapeutic binding molecules

Details for Australian Patent Application No. 2004272289 (hide)

Owner Novartis AG

Inventors Roncarolo, Maria Grazia; Jeschke, Margit; Aszodi, Andras; Hall, Bruce M.; Kolbinger, Frank; Carballido Herrera, Jose M.; Loux, Veronique; Gregori, Silvia; Aversa, Gregorio; Saldanha, Jose W.

Agent Davies Collison Cave

Pub. Number AU-B-2004272289

PCT Pub. Number WO2005/026210

Priority 0414309.5 25.06.04 GB; 10/666,332 18.09.03 US

Filing date 17 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 18 September 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/79 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for eukaryotic hosts

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026210 Priority application(s): WO2005/026210

18 September 2008 Application Accepted

  Published as AU-B-2004272289

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272302-Chimeric GABAb receptor

2004272288-2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders